Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1998-01-22
1999-11-16
Brouillette, D. Gabrielle
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
514946, 514947, A61F 1302
Patent
active
059853115
ABSTRACT:
A transdermal therapeutic system (TTS) which contains as the active ingredients an oestrogen and a gestagen or a gestagen or androgen as well as an acrylate adhesive and, as resorption promoters, the two substances oleic acid and 2-(2-ethoxyethoxy)ethanol.
REFERENCES:
patent: 4913905 (1990-04-01), Fankhauser et al.
patent: 5053227 (1991-10-01), Chiang
patent: 5194455 (1993-03-01), Massow
patent: 5223261 (1993-06-01), Nelson et al.
patent: 5296230 (1994-03-01), Chien et al.
patent: 5306503 (1994-04-01), Muller et al.
patent: 5314685 (1994-05-01), Tyle et al.
patent: 5393529 (1995-02-01), Hoffmann et al.
patent: 5518734 (1996-05-01), Stefano
patent: 5676968 (1997-10-01), Lipp et al.
patent: 5686098 (1997-11-01), Murphy
patent: 5711962 (1998-01-01), Cordes et al.
Franz, "Percutaneous Absorption on the Relevance of In Vitro Data", The Jnal of Investigate Dermatology, 64:190-195 (1975).
Katz et al., "Enhanced skin Permeation of Prazosin by Transcutol-Oleic Acid Mixture", Proceed. Intern. Symp. Control. Rel. of Bioact. Mater., 18: 533-534 (1991).
Frieg-Falson et al., "Characterization of the Enhancing Effect of a Vehicle in a Transdermal System", Drug Development and Industrial Pharmacy, 15(14-16), 2393-2406 (1989).
Watkinson et al., "Aspects of the Transdermal Delivery of Prostaglandins", International Journal of Pharmaceutics, 74 (1991) 229-256.
Walters et al., "Penetration Enhancers and Their Use in Transdermal Therapeutic Systems", Transdermal Drug Delivery: Developmental Issues and Research Initiatives, edited by Hadgraft and Guy, Marcel Dekker, Inc., 1989, pp.
Abstract of Katz et al., "Enhanced Skin Permeation of Prazosin by Transutol-oleic Acid Mixture", Proc. Program. Int. Symp. Controlled Release Bioact. Mater., 18.sup.th (1991) 533-544.
Abstract of Rieg-Falson et al., "Evaluation of a Transdermal Device Containing Testosterone", Bull. Tech./Gattefosse Rep., 78: 89-96 (1985).
Abstract of Published Canadian Patent Application No. CA 2,012,875 (1990).
Cordes Guenter
Siegmund Martin
Brouillette D. Gabrielle
Labtec Gesellschaft fuer techologische Forschung und Entwicklung
LandOfFree
Transdermal hormone patch does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal hormone patch, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal hormone patch will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1320915